Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 163,666 shares of the firm’s stock in a transaction that occurred on Monday, January 13th. The shares were purchased at an average price of $0.61 per share, for a total transaction of $99,836.26. Following the transaction, the chief executive officer now owns 3,937,980 shares of the company’s stock, valued at $2,402,167.80. The trade was a 4.34 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Grigorios Siokas also recently made the following trade(s):
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were purchased at an average price of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Trading Up 16.3 %
Shares of COSM opened at $0.80 on Thursday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. Cosmos Health Inc. has a 12 month low of $0.47 and a 12 month high of $1.58. The stock has a market cap of $18.61 million, a PE ratio of -0.33 and a beta of 5.56. The stock’s 50-day moving average is $0.71 and its two-hundred day moving average is $0.91.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Read More
- Five stocks we like better than Cosmos Health
- What does consumer price index measure?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Golden Cross Stocks: Pattern, Examples and Charts
- How Do Stock Buybacks Affect Shareholders?
- 3 Dividend Kings To Consider
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.